Patheon, Inc.

Mark Kontny, Ph.D. has joined Patheon, Inc. as president of Global Pharmaceutical Development Services (PDS) and as its chief scientific officer. Dr. Kontny joins the company from Abbott Laboratories, where he was divisional vice president, Global Pharmaceutical and Analytical Sciences, for the global pharmaceutical R&D organization.

“Mark has developed a well deserved reputation for combining strong technical abilities with excellent leadership skills. We look forward to him quickly integrating into the Patheon leadership team and helping us drive our PDS business to an even higher performance level,” said Wes Wheeler, Patheon’s chief executive officer and president.

“I am delighted to join Patheon and look forward to leading the PDS organization to provide best in class development services to accelerate customer molecules to market,” said Dr. Kontny.

Dr. Kontny has nearly 25 years of industry experience having held positions of increasing responsibility at Ventaira Pharmaceuticals, Boehringer-Ingelheim, Monsanto-G.D. Searle, Pharmacia and Pfizer.

Click here to learn more about Patheon